Signaling pathways
-
BA8837 NRX-0492Summary: NRX-0492 is an orally effective degradant. - BA8838 BMS-935177Summary: BMS-935177 is a potent, selective, and reversible Bruton's tyrosine kinase inhibitor.
- BA8839 AtuzabrutinibSummary: Atuzabrutinib (SAR444727) is a potent, selective reversible inhibitor.
- BA8840 JS25Summary: JS25 is a selective covalent inhibitor (=5.8 nM) that is inactivated by chelation.
- BA8841 EdralbrutinibSummary: An inhibitor.
- BA8844 DD-03-171Summary: DD-03-171 is a degrading agent.
- BA8845 BTK-IN-29Summary: An inhibitor.
- BA8847 CSF1R-IN-24Summary: CSF1R-IN-24 is an orally active inhibitor.
- BA8848 EdicotinibSummary: Edicotinib (JNJ-40346527) is a potent and selective inhibitor of blood-brain permeability and oral activity.
- BA8849 SeralutinibSummary: Seralutinib is an inhalable kinase inhibitor.